Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.40 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.40 |
| ▸ | MME | P08473 | 1/20 | 0.39 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16586532 | 0.95 | ALDH1A1 (0.42) | ALDH1A1HSD17B10CNR2MAPTPOLB | |
| SCHEMBL3664377 | 0.94 | ALDH1A1 (0.44) | ALDH1A1HSD17B10CNR2MAPTPOLB | |
| SCHEMBL28419011 | 0.94 | ALDH1A1 (0.44) | ALDH1A1HSD17B10CNR2MAPTPOLB | |
| SCHEMBL28419027 | 0.94 | ALDH1A1 (0.44) | ALDH1A1HSD17B10CNR2MAPTPOLB | |
| SCHEMBL3664559 | 0.94 | ALDH1A1 (0.44) | ALDH1A1HSD17B10CNR2MAPTPOLB | |
| SCHEMBL28416201 | 0.94 | ALDH1A1 (0.44) | ALDH1A1HSD17B10CNR2MAPTPOLB | |
| SCHEMBL1162115 | 0.90 | PPARG (0.39) | ALDH1A1HSD17B10POLBKDM4EPPARG | |
| SCHEMBL19951679 | 0.90 | PPARG (0.39) | ALDH1A1HSD17B10POLBKDM4EPPARG | |
| Methane SCHEMBL28344019 | 0.89 | PPARG (0.38) | ALDH1A1HSD17B10POLBKDM4EPPARG | |
| Hydrochloric Acid SCHEMBL21405660 | 0.83 | LMNA (0.40) | ALDH1A1HSD17B10SMN1; SMN2POLBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106749373-B | Rubber additive and preparation and application thereof | 同济大学 | 2020-06-26 | — | — | CN | disclosed |
| US-10265693-B2 | Particles, particle dispersion, particle-dispersed resin composition, producing method therefor, resin molded article, producing method therefor, catalyst particles, catalyst solution, catalyst composition, catalyst molded article, titanium complex, titanium oxide particles and producing method therefor | NITTO DENKO CORPORATION (JP) | 2019-04-23 | — | — | US | disclosed |
| US-9847544-B2 | Ion conductive organic-inorganic composite particles, particle-containing resin composition and ion conductive molded article | NITTO DENKO CORPORATION (JP) | 2017-12-19 | — | — | US | disclosed |
| EP-2409569-B1 | Method for administering GLP-1 molecules | EMISPHERE TECH INC (US) | 2017-08-16 | — | — | EP | disclosed |
| US-20170189895-A1 | PARTICLES, PARTICLE DISPERSION, PARTICLE-DISPERSED RESIN COMPOSITION, PRODUCING METHOD THEREFOR, RESIN MOLDED ARTICLE, PRODUCING METHOD THEREFOR, CATALYST PARTICLES, CATALYST SOLUTION, CATALYST COMPOSITION, CATALYST MOLDED ARTICLE, TITANIUM COMPLEX, TITANIUM OXIDE PARTICLES AND PRODUCING METHOD THEREFOR | NITTO DENKO CORPORATION (JP) | 2017-07-06 | — | — | US | disclosed |
| EP-1478233-B1 | METHOD FOR ADMINISTERING GLP-1 MOLECULES | EMISPHERE TECH INC (US) | 2016-11-09 | — | — | EP | disclosed |
| US-20160222194-A1 | PARTICLES, PARTICLE DISPERSION, PARTICLE-DISPERSED RESIN COMPOSITION, PRODUCING METHOD THEREFOR, RESIN MOLDED ARTICLE, PRODUCING METHOD THEREFOR, CATALYST PARTICLES, CATALYST SOLUTION, CATALYST COMPOSITION, CATALYST MOLDED ARTICLE, TITANIUM COMPLEX, TITANIUM OXIDE PARTICLES AND PRODUCING METHOD THEREFOR | NITTO DENKO CORPORATION (JP) | 2016-08-04 | — | — | US | disclosed |
| EP-1015008-B1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECH INC (US) | 2015-08-05 | — | — | EP | disclosed |
| US-20150202296-A1 | METHOD FOR ADMINISTERING GLP-1 MOLECULES | NOVO NORDISK NORTH AMERICA OPERATIONS A/S (DK) | 2015-07-23 | — | — | US | disclosed |
| US-20150065340-A1 | PARTICLES, PARTICLE DISPERSION, PARTICLE-DISPERSED RESIN COMPOSITION, PRODUCING METHOD THEREFOR, RESIN MOLDED ARTICLE, PRODUCING METHOD THEREFOR, CATALYST PARTICLES, CATALYST SOLUTION, CATALYST COMPOSITION, CATALYST MOLDED ARTICLE, TITANIUM COMPLEX, TITANIUM OXIDE PARTICLES AND PRODUCING METHOD THEREFOR | NITTO DENKO CORPORATION (JP) | 2015-03-05 | — | — | US | disclosed |
| US-6051561-A | MIXTURE OF ACTIVE MATERIAL AND A CARBOXYLATED PHENOL COMPOUND | EMISPHERE TECHNOLOGIES INC. (US) | 2000-04-18 | — | — | US | disclosed |
| US-5990166-A | O-(1-CARBOXYOCTYLCARBONYLAMINO)PHENOL AS A CARRIER; DRUG DELIVERY; ACID RESISTANCE; FORMING NONCOVALENT MIXTURES WITH BIOLOGICALLY ACTIVE AGENTS FOR ORAL ADMINISTRATION; E.G., CALCITONIN, INSULIN, POLYSACCHARIDES, MUCOPOLYSACCHARIDES | EMISPHERE TECHNOLOGIES, INC. (US) | 1999-11-23 | — | — | US | disclosed |
| WO-1998034632-A9 | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECH INC (US) | 1999-09-02 | — | — | WO | disclosed |
| US-5939381-A | 4-(4-(PHENOXYACETYL)AMINOPHENYL)BUTYRIC ACID AS A CARRIER FOR DRUG DELIVERY | EMISPHERE TECHNOLOGIES, INC. (US) | 1999-08-17 | — | — | US | disclosed |
| US-5879681-A | Compounds and compositions for delivering active agents | EMISPHERE TECHNOLGIES INC. (US) | 1999-03-09 | — | — | US | disclosed |
| US-5876710-A | DRUG DELIVERY; USING A BROMINATED BENZAMIDE COMPOUND | EMISPHERE TECHNOLOGIES INC. (US) | 1999-03-02 | — | — | US | disclosed |
| US-5804688-A | 6-N-(3,5-DICHLORO-2-HYDROXYBENZOYL)AMINOCAPROIC ACID | EMISPHERE TECHNOLOGIES, INC. (US) | 1998-09-08 | — | — | US | disclosed |
| WO-1998034632-A1 | COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECHNOLOGIES, INC. (US) | 1998-08-13 | — | — | WO | disclosed |
| US-5776888-A | 3-(DIMETHOXYBENZOYLAMINOPHENYL) PROPIONIC ACID | EMISPHERE TECHNOLOGIES, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5773647-A | USING A AROMATIC COMPOUND CONTAINING AMIDE AND CARBOXY GROUPS | EMISPHERE TECHNOLOGIES, INC. (US) | 1998-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150202296-A1 | METHOD FOR ADMINISTERING GLP-1 MOLECULES | GLP1R, GIPR, GPR119 | ALDH1A1 3386/4885HSD17B10 2528/4885CNR2 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.